Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGION-I: PEP005 (Ingenol Mebutate) Gel for Actinic Keratosis on Trunk and Extremities
NCT00742391Phase 3Completed
- Sponsor
- Peplin
- Start
- Sep 2008
- Primary completion
- Feb 2009
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Peplin. Started Sep 2008; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00742391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742391.